VEEV241115P250000
- 27.40
- 0.000.00%
Veeva Systems Newsroom
Veeva to Release Fiscal 2025 Third Quarter Results on December 5, 2024
William Blair Maintains Veeva Systems(VEEV.US) With Buy Rating
Veeva Systems: Strong Market Position and Future Growth Potential Drive Buy Rating
Boehringer Ingelheim Commits to Veeva Vault CRM
Veeva Pulse Data Shows New Science Calls for More Connected Engagement
Reasons to Retain Veeva Systems Stock in Your Portfolio Now
Veeva Systems Insider Sold Shares Worth $270,252, According to a Recent SEC Filing
BTIG Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $280
BTIG Remains a Buy on Veeva Systems (VEEV)
Veeva Systems (VEEV) Laps the Stock Market: Here's Why
Jefferies Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $280
Baird Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $275
Veeva (VEEV) Surges 5.2%: Is This an Indication of Further Gains?
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Veeva Systems (VEEV) and Neuren Pharmaceuticals Limited (OtherNURPF)
Is Veeva Systems Inc.'s (NYSE:VEEV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $230 to $280
Express News | Ishijian China: Anesthesiology and other fields will become key business directions for the company.
Express News | Barclays has raised Veeva Systems' target stock price from $240.00 to $260.00.
Veeva Systems Is Maintained at Outperform by RBC Capital
Express News | Veeva Systems Inc : UBS Raises Target Price to $245 From $215